Ampio Pharm Top Management

AMPEDelisted Stock  USD 0.24  0.01  4.35%   
Ampio Pharm employs about 6 people. The company is managed by 8 executives with a total tenure of roughly 14 years, averaging almost 1.0 years of service per executive, having 0.75 employees per reported executive. Evaluation of Ampio Pharm's management performance can provide insight into the firm performance.
CPA CPA  Insider
Corp CFO
Laura Goldberg  Insider
VP Operations
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Ampio Pharm Management Team Effectiveness

The company has return on total asset (ROA) of (0.6157) % which means that it has lost $0.6157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1396) %, meaning that it created substantial loss on money invested by shareholders. Ampio Pharm's management efficiency ratios could be used to measure how well Ampio Pharm manages its routine affairs as well as how well it operates its assets and liabilities.

Ampio Pharm Workforce Comparison

Ampio Pharm is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 778. Ampio Pharm maintains roughly 6.0 in number of employees contributing less than 1% to equities under Health Care industry.

Ampio Pharm Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ampio Pharm insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ampio Pharm's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Ampio Pharm insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ampio Pharm Notable Stakeholders

An Ampio Pharm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ampio Pharm often face trade-offs trying to please all of them. Ampio Pharm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ampio Pharm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel CPACorporate CFOProfile
CPA CPACorp CFOProfile
Laura GoldbergVP OperationsProfile
MBBCh MMMChief OfficerProfile
Lane HapkeVP OperationsProfile
April RamirezClinical ManagerProfile
Michael MartinoCEO DirectorProfile
David MDFounder BoardProfile

About Ampio Pharm Management Performance

The success or failure of an entity such as Ampio Pharm often depends on how effective the management is. Ampio Pharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ampio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ampio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.
Please note, the presentation of Ampio Pharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ampio Pharm's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ampio Pharm's management manipulating its earnings.

Ampio Pharm Workforce Analysis

Traditionally, organizations such as Ampio Pharm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ampio Pharm within its industry.

Ampio Pharm Manpower Efficiency

Return on Ampio Pharm Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.4M
Net Loss Per Executive1.1M
Working Capital Per Employee560K
Working Capital Per Executive420K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Ampio Pink Sheet

If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data